The Latest Cardiac and Vascular News
HOOFDDORP, The Netherlands–(BUSINESS WIRE)–OMRON Healthcare Europe announced that David Menko has been appointed as the company’s President and Chief Executive Officer effective December 1st. David Menko succeeds André van Gils who steps down as CEO for Europe and will continue to lead the global organization in his role of Senior […]
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Tenaya Therapeutics, Inc. (NASDAQ:TNYA), a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, today announced changes to its Board of Directors including the addition of June Lee, M.D., and the transition of JJ Kang, […]
New indication expands addressable market for Pantheris REDWOOD CITY, CA / ACCESSWIRE / November 17, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced that it has received 510(k) clearance […]
PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has extended the review of the New Drug Application (NDA) for mavacamten for the treatment of patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) to April 28, 2022. The FDA notified Bristol Myers Squibb on […]
MALVERN, Pa. & SAN DIEGO–(BUSINESS WIRE)–PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, today announced the appointment of Jonathan J. Birchall as Chief Commercial Officer. “Jonathan brings to PhaseBio deep commercial expertise in the critical-care setting, which he […]
– Revenues Increased 23% Year-over-Year to $13.6 Million – – U.S. WatchPAT™ Revenues Increased 27% Year-over-Year to $11.3 Million – CAESAREA, Israel, Nov. 18, 2021 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (Nasdaq and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, today reported unaudited financial results […]
LONGMONT, Colo., Nov. 18, 2021 /PRNewswire/ — Proximo Medical, LLC, a business acceleration solution that addresses medical device commercialization challenges among startup and established medical device technologies looking to expand adoption in the U.S., today announced a partnership with Acarix, a Swedish medical device company that provides innovative solutions for rapid AI-based rule out of […]
CAESAREA, Israel, Nov. 18, 2021 /PRNewswire/ — Filterlex Medical, a cardiovascular medical device startup, announced today that it has recently completed a US $6 Million series A1 investment round from leading private healthcare investors. The financing will accelerate implementation of the company’s CAPTIS® clinical program. The CAPTIS is a next-generation, full-body embolic protection device to reduce […]
Novocardia Joins List of Fast-Growing Private Companies Transforming Health Care Delivery & Outcomes NEW YORK, Nov. 18, 2021 /PRNewswire/ — Novocardia, a value-based cardiovascular disease care delivery platform, today announced it has been named a “Rising Disruptor” by Bernstein, a global equity research firm, in its 2021 report on the most disruptive private […]
ENGLEWOOD, Colo., Nov. 18, 2021 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics today announced it has been ranked 7th in revenue growth among all medical device companies in the U.S. and Canada on Deloitte’s 2021 […]
